
Biovet, part of Bharat Biotech, has received approval from the CDSCO for its innovative lumpy skin disease vaccine, BIOLUMPIVAXIN, for dairy cattle and buffaloes. The vaccine, developed using a strain from ICAR-NRCE, can produce 500 million doses annually and will be crucial for India's dairy sustainability and disease eradication efforts.
Post a Comment